Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06895525
NA

Efficacy of HellenCare in Early-Stage Alzheimer's Disease

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate whether HellenCare, a multicomponent nutraceutical, improves cognitive and functional outcomes in patients with early-stage Alzheimer's disease (AD). The investigators will compare changes in outcomes between the HellenCare group and the placebo group to determine if the intervention is effective and safe.

Official title: The HEART Study: A Randomized, Double-Blind, Parallel Placebo-Controlled Trial on the Efficacy of HellenCare in Early-Stage Alzheimer's Disease

Key Details

Gender

All

Age Range

50 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-04-15

Completion Date

2025-12-31

Last Updated

2025-04-08

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

HellenCare

2 g, twice daily, to be taken on an empty stomach.

DIETARY_SUPPLEMENT

Placebo

2 g, twice daily, to be taken on an empty stomach.